Careers  |  Sign In  |  Register  |   Twitter

Medtronic Heart Valve Replacement More Successful Than Surgery

According to Reuters, a study presented at an American College of Cardiology conference has found that patients who received the Medtronic CoreValve non-invasive heart valve replacement device were better off two years post procedure compared to those who underwent open heart surgery. The rate of all-cause mortality or major stroke after one year for patients receiving the Medtronic device was 16.2 percent compared to 22.5 percent of surgery patients. After two years, Medtronic patients saw a mortality rate of 24.2 percent compared to 32.5 percent of surgery patients. The study leader says that the findings are strong enough that this device should become the preferred method and not just an alternative option to surgery, specifically among the high-risk surgical population.

Read the article published by Reuters.

Read the report published by the American College of Cardiology.